Evidence map›Paper›PMID 30572496›Full record

ArticleMedicine2018

Fuling Sini decoction for patients with chronic heart failure: A protocol for a systematic review and meta-analysis.

Lijie Huang, Hairong Cai, Jieqin Zhuang, Yanhong Chen, Zilin Jin, Haobo Zhang, Huanjia Gao

Abstract read
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lijie HuangThe Basic Medicine College of Guangzhou University of Chinese Medicine.
Hairong CaiThe Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Jieqin ZhuangThe Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Yanhong ChenThe Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Zilin JinThe Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Haobo ZhangThe Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Huanjia GaoThe Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic heart failure (CHF) is one of the most important cardiovascular diseases worldly, with high morbidity and mortality. Fuling Sini decoction (FSD) has been used in the management of CHF widely in China, while its effective evidence is not clear. A systematic review and meta-analysis to evaluate FSD for CHF is lacking. Hence, we propose a protocol for systematic evaluation of its efficacy and safety for CHF.

methodsWe will search the following electronic databases from inception to October 2018, including EMBASE, Cochrane Center Registration Controlled trials (Cochrane Library), PubMed, Medline, WHO International Clinical Trials Registry Platform, China Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), and Wan-fang database. Only randomized controlled trials (RCTs) of FSD alone or combined with other management for CHF will be included. Two independent reviewers will screen the literature and extract data according to the Cochrane Handbook method. The assessment of bias risk, data synthesis, subgroup analysis, and meta-analyses and finally meta-analysis will be performed by using RevMan V.5.3.5 software.

resultsThis systematic review will provide high-quality evidence and may be the first to evaluate efficacy and safety of FSD in the treatment of CHF.

conclusionThis systematic review will provide evidence for judging whether FSD is an effective management for CHF or not. PROSPERO REGISTRATION NUMBER: CRD 42018110210.

Indexed as

Drugs, Chinese HerbalHeart FailureWolfiporiaHumansMedicine, Chinese TraditionalMeta-Analysis as TopicPhytotherapySystematic Reviews as TopicDrugs, Chinese Herbalsini tang

Identifiers

PMID30572496
PMCPMC6320152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.